2 years after leaving PhRMA, AstraZeneca opts back in
Title
AstraZeneca Rejoins PhRMA After Two-Year Hiatus
Keywords
- AstraZeneca
- PhRMA
- Pharmaceutical industry
- Industry associations
- Trade groups
- Policy advocacy
- Membership
- Pharma lobbying
- Health equity
Key Facts
- AstraZeneca has rejoined the Pharmaceutical Research and Manufacturers of America (PhRMA) after a two-year absence from the industry trade association12.
- The company’s return was officially welcomed by PhRMA in April 20252.
- AstraZeneca’s initial departure from PhRMA occurred two years prior; details about the reasons for both the exit and the return were not specified in the cited sources12.
- AstraZeneca’s membership in PhRMA allows the company to participate in collective industry advocacy efforts, influence pharmaceutical policy, and collaborate on initiatives related to health equity and innovation23.
- The return reflects ongoing industry alignment and AstraZeneca’s continued commitment to policy engagement and collaboration within the U.S. pharmaceutical sector2.
- AstraZeneca continues to invest in public health initiatives, such as health equity programs and community support, aligning with broader industry goals35.
Sources:
1. https://firstwordpharma.com/story/5951461
2. https://phrma.org/resources/phrma-welcomes-astrazeneca-to-the-association
3. https://www.astrazeneca-us.com/media/astrazeneca-us-blog/2024/act-on-health-equity-contributions-recipient-announcement.html
5. https://www.astrazeneca-us.com/sustainability/Request-Support/medical-education-office.html